BAA contract titled, "in vivo predictive dissolution (IPD) to advance oral product bioequivalence (be) regulation."
Ended Definitive Contract Awarded Last action
- Contract number
- HHSF223201510157C
- Awardee
-
Regents Of The University Of Michigan UEI GNJ7BBP73WE9
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,762,608
Award facts
- Opportunity
-
- FDABAA1500121 Solicitation number
- Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science Award Notice · Posted Feb 23, 2015
- Contract value 37% obligated
-
- $2,762,608.00 Current, with exercised options
- $7,369,588.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Ann Arbor, MI 48109, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$31,864 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $1,546,294 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,248,178 |
About this award
This $7,369,588 federal contract was awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan. The contract is titled "In Vivo Predictive Dissolution (IPD) to Advance Oral Product Bioequivalence (BE) Regulation" and aims to develop improved methods for assessing the bioequivalence of oral drug products. The contract has three main objectives: 1) Mass transport analysis of the gastrointestinal tract, 2) Development and validation of gastrointestinal MRI studies, and 3) Advanced in vivo predictive dissolution methodologies.
The prime contractor, the University of Michigan, has subcontracted portions of the work to the University of Colorado and University of Nottingham. The contract does not utilize any set-aside designations. Through this contract and other federal awards, the University of Michigan has established itself as a provider of research and development services to federal agencies like the Department of Defense and NASA, with expertise spanning scientific disciplines from cybersecurity to fusion energy physics.
Quick answers
Who was awarded contract HHSF223201510157C?
HHSF223201510157C was awarded to Regents Of The University Of Michigan by Food and Drug Administration (Department of Health and Human Services) on September 15, 2015.
How much is contract HHSF223201510157C worth?
The government has obligated $2,762,608 on HHSF223201510157C. Its potential value, with all options, is $7,369,588.
Was contract HHSF223201510157C competed?
The extent of competition for HHSF223201510157C was full and open competition. The government received 8 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award